ADR Ratio Change
22 juin 2023 16h15 HE
|
Biodexa Pharmaceuticals PLC
22 June 2023 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) ADR Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical-stage biopharmaceutical company developing a pipeline of...
Appeal of Delisting Determination
20 juin 2023 08h00 HE
|
Biodexa Pharmaceuticals PLC
20 June 2023 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Appeal of Delisting Determination Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical-stage biopharmaceutical company...
Biodexa Pharmaceuticals PLC Announces Closing of $3.32 Million Registered Direct Offering
26 mai 2023 16h05 HE
|
Biodexa Pharmaceuticals PLC
26 May 2023 Biodexa Pharmaceuticals PLC Announces Closing of $3.32 Million Registered Direct Offering Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (NASDAQ: BDRX), a...
Biodexa Pharmaceuticals PLC Announces US$3.32 Million Registered Direct Offering
24 mai 2023 08h40 HE
|
Biodexa Pharmaceuticals PLC
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH...
Posting of Annual Report & Notice of AGM
22 mai 2023 16h15 HE
|
Biodexa Pharmaceuticals PLC
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Posting of Annual Report & Notice of AGM Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a clinical stage biopharmaceutical company...
Biodexa Pharmaceuticals Enters into Non-binding Letter of Intent for Proposed Acquisition of Varian Biopharmaceuticals
18 mai 2023 08h30 HE
|
Biodexa Pharmaceuticals PLC
18 May 2023 Biodexa Pharmaceuticals Enters into Non-binding Letter of Intent for Proposed Acquisition of Varian Biopharmaceuticals Biodexa Pharmaceuticals PLC (NASDAQ: BDRX) (“Biodexa” or the...
Basal Cell Carcinoma Market to Grow at a Substantial Growth Rate | MEDIVIR, Biofrontera Bioscience, Mediwound, AiViva's, Sirnaomics, Pellepharm, Senhwa Biosciences, Inc., Palvella Therapeutics, Inc., and Others Expected to Propel Market
05 avr. 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, April 05, 2023 (GLOBE NEWSWIRE) -- Basal Cell Carcinoma Market to Grow at a Substantial Growth Rate | MEDIVIR, Biofrontera Bioscience, Mediwound, AiViva's, Sirnaomics, Pellepharm,...
Basal Cell Carcinoma Treatment Market to Reach US$ 15 Billion in 2033; Amid Rising Incidences of Skin Cancer
07 févr. 2023 09h00 HE
|
FACT.MR
Rockville, Feb. 07, 2023 (GLOBE NEWSWIRE) -- The basal cell carcinoma therapy market report provided by Fact.MR examines significant drivers of growth that have effects on sales. The research...
Basal Cell Carcinoma Treatment Market Report Up to 2031: Visiongain Research Inc
06 déc. 2021 09h30 HE
|
Visiongain Ltd
Visiongain has published a new report on Basal Cell Carcinoma Treatment Market Report to 2031. Profiles of Leading Basal Cell Carcinoma Treatment Market players, Regional and Leading National Market...
Basal Cell Carcinoma Treatment Market Value Anticipated To Reach US$ 11.5 Billion By 2027: Acumen Research And Consulting
09 mars 2021 10h09 HE
|
Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Basal Cell Carcinoma Treatment Market– Global Industry Analysis, Market Size,...